For the first time, scientists have proven that applying these plant-based compounds can trigger a critical signaling chain in human cells, forcing dormant hair follicles to enter their active growing phase and physically lengthen human hair shafts. This discovery bridges the gap between natural organic remedies and high-tech genetic therapies, opening up an entirely new, non-hormonal path to combat pattern baldness.
What Is It and How Does It Work?
SCUBE3 (Signal peptide-CUB-EGF-like domain-containing protein 3) is a natural “messenger protein” produced inside the dermal papilla cells, which act as the control center at the base of every hair follicle.
Think of the hair growth cycle like a traffic light. In pattern baldness, the light gets stuck on red (the resting, or telogen phase) because the control center malfunctions and stops sending “go” signals.
-
The “Go” Signal: SCUBE3 is the body’s natural “go” signal. When abundant, it tells neighboring hair stem cells to divide, turning the hair cycle’s light back to green (the growth, or anagen phase).
-
The Power Booster: The new study reveals that Ageratum houstonianum extract and its active constituent molecule, agerarin, act as a power switch for this signal.
-
The MAPK Pathway: When applied, they activate a specific cellular highway called the MAPK-AP-1 (Mitogen-Activated Protein Kinase / Activator Protein-1) pathway. This pathway sends instructions to the cell’s nucleus, turning up the volume on the SCUBE3 gene and flooding the follicle with the growth-inducing messenger proteins needed to build thick hair.
Because this mechanism focuses entirely on local cellular signaling pathways rather than blocking testosterone or dihydrotestosterone (DHT) systemically, it avoids the hormonal and sexual side effects associated with traditional daily hair loss pills.
The Science: Human Scalp Follicles Elongate in Lab Setting
The study, published in the International Journal of Molecular Sciences, tested these natural compounds in an ex vivo human hair follicle organ culture model—meaning they grew living human scalp follicles in a controlled laboratory environment for six days.
To measure how well the treatment worked, the researchers tracked MOD (Mean of Difference) and the Anagen Population:
What is MOD? MOD stands for Mean of Difference. It is the precise scientific metric used to measure hair shaft elongation. Scientists take calibrated digital photographs of human hair follicles on Day 0 and again on Day 6, then subtract the starting length from the ending length to calculate exactly how many millimeters of new hair shaft have been physically produced.
What is the Anagen Population? This refers to the percentage of hair follicles that are actively in their growth phase. Scientists identify this by looking at the shape and structural characteristics of the hair follicle base under a high-powered microscope.
-
Measurable Elongation: Human scalp follicles treated with 50 μg/mL of the flower extract or 50 μM of pure agerarin showed a highly significant increase in hair shaft elongation (MOD) compared to the untreated control group.
-
More Growing Follicles: The treatment successfully increased the percentage of the hair follicles that remained in or entered the active growth (anagen) phase.
-
Upregulating SCUBE3 at the Source: In human dermal papilla cells, both treatments dramatically boosted both the mRNA (the genetic blueprint) and protein levels of SCUBE3. The statistical significance of this protein increase was incredibly strong (p = 0.001 for the extract and p < 0.0001 for agerarin), proving the growth was directly driven by the targeted SCUBE3 boost.
Read next
Whats the best shampoo for hair loss?
“In a hair follicle organ culture model, both AHE [Ageratum extract] and agerarin increased the population of the anagen phase and promoted hair shaft elongation… AHE and agerarin may serve as potential therapeutic agents for the prevention and treatment of alopecia.” — Study Researchers, Department of Biological Sciences, Konkuk University.
When Will It Be Available?
-
Current Stage: This study represents a newly published scientific breakthrough using human tissues in a laboratory setting.
-
Timeline: The active constituent, agerarin, is currently being researched for further cosmetic and dermatological applications by Korean skin-science firm AgeraMedi. Experts estimate that a highly purified, medical-grade topical agerarin serum could enter formal human safety and efficacy trials in the next 18 to 24 months, with a projected market launch around 2029.
How you can benefit from this treatment now
While highly concentrated, clinical-grade agerarin is still moving through the regulatory pipeline, the validation of the SCUBE3 pathway offers practical steps you can take today:
-
Track the SCUBE3 Pipeline: The biotechnology firm Amplifica Holdings Group is actively developing a pipeline drug called AMP-601, which is a specialized therapy specifically designed around the SCUBE3 protein. Keep a close eye on Amplifica’s clinical trial updates to see when this therapeutic candidate enters human testing.
-
Support Your Scalp’s Signaling Pathways: This study proves that activating the MAPK pathway is the key to signaling your body to produce its own SCUBE3. You can support this cellular environment naturally by discussing Low-Level Laser Therapy (LLLT) or clinical microneedling with a dermatologist. Both physical therapies have been shown to help regulate local growth factors and stimulate cell signaling pathways.
-
Do Not Attempt DIY Bluemink/Flossflower Extracts: Ageratum houstonianum (commonly known as bluemink or flossflower) is a very common garden flower. However, experts strongly warn against making home remedies or topical oils from the raw plant. Raw flossflower contains toxic alkaloids that can cause severe liver damage or chemical skin burns if not processed, isolated, and purified in a professional, sterile laboratory environment.
[cite: 1, 2]